PCT Blend
PCT Blend Product Description — Research Use Only
PCT Blend is a research-use compound blend containing Laxogenin (50MG) and Arimistane (25MG). It is not a peptide blend; Laxogenin is commonly discussed as a spirostane-type steroid derivative, while Arimistane, also known as androsta-3,5-diene-7,17-dione, is commonly studied in relation to aromatase-inhibition and hormone-response pathways.
Research on PCT-style blends most commonly focuses on body-composition markers, muscle-support pathways, estrogen-related signaling, aromatase activity, hormone-response research, recovery-related pathways, and endocrine balance markers. Scientific literature on Laxogenin remains limited, with studies mainly evaluating its androgenic properties, supplement identification, and potential muscle-cell research applications. Arimistane has been identified in supplement-analysis literature as a designer steroid that may function as an aromatase inhibitor.
PCT Blend is commonly studied for:
Body-composition research — markers related to lean mass, fat mass, and physique-related changes
Muscle-support pathways — signals connected to muscle maintenance, repair, and protein balance
Aromatase activity — how compounds may influence estrogen-conversion pathways
Estrogen-response markers — how estrogen-related signaling is regulated in research settings
Hormone-balance research — how androgen and estrogen pathways interact
Recovery research — pathways connected to restoration after endocrine or performance-related stress
Compound-combination research — how Laxogenin and Arimistane behave in the same research model
PCT Blend is commonly studied because its two ingredients are associated with different research targets. Laxogenin-related research is most often connected to muscle-cell, anabolic-pathway, and body-composition interest, although human clinical evidence is limited. Arimistane-related research is generally discussed around aromatase-inhibition, estrogen-response pathways, and endocrine signaling. Because of the limited direct clinical literature on this exact combination, this blend is best positioned for controlled research involving hormone-response markers, aromatase activity, body-composition pathways, and recovery-related endocrine signaling.
For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.